ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, G.
Right arrow Articles by van der Poll, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, G.
Right arrow Articles by van der Poll, T.
Eur Respir J 2004; 24:786-789
Copyright ©ERS Journals Ltd 2004

Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection

G. Choi1,2,3, M.J. Schultz1,3, J.W.O. van Till4, P. Bresser5, J.S. van der Zee5, M.A. Boermeester4, M. Levi2 and T. van der Poll2,3

Depts of 1 Intensive Care Medicine, 2 Internal Medicine, 3 Laboratory of Experimental Internal Medicine, 4 Surgery, and 5 Pulmonology, Academic Medical Centre, University of Amsterdam.

CORRESPONDENCE: G. Choi, Academic Medical Centre, University of Amsterdam, Dept of Intensive Care Medicine, C3-423, Meibergdreef 9, 1108 AZ, Amsterdam, the Netherlands. Fax: 31 205669568. E-mail: GodaChoi@mail.com

Keywords: Bronchoalveolar lavage fluid, coagulation, fibrinolysis, mechanical ventilation, plasma, pneumonia

Received: December 19, 2003
Accepted June 26, 2004

Severe infection is associated with profound alterations in the systemic haemostatic balance, with activation of coagulation and suppressed fibrinolysis. Within the alveolar compartment, similar disturbances have been described during pulmonary inflammation. The current authors investigated whether local haemostasis was influenced during ventilator-associated pneumonia (VAP).

In five patients with unilateral VAP, bronchoalveolar lavage fluid (BALF) was obtained from both the infected site (as identified on chest radiograph) and the contralateral noninfected lung (with no clinical or radiographic abnormalities). Markers for coagulation and fibrinolysis were compared between infected and noninfected lungs. A total of 10 healthy volunteers and 10 mechanically ventilated patients without pneumonia served as controls.

Strong activation of coagulation (high levels of thrombin-antithrombin complexes, soluble tissue factor and factor VIIa) was detected in BALF from infected lungs, compared with that from noninfected lungs and controls. Furthermore, in infected lungs, fibrinolysis was depressed, with high levels of plasminogen activator inhibitor type 1.

In conclusion, ventilator-associated pneumonia is characterised by a hypercoagulant state at the site of infection.




This article has been cited by other articles:


Home page
J Intensive Care MedHome page
J. E. Levitt, M. K. Gould, L. B. Ware, and M. A. Matthay
Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury
J Intensive Care Med, May 1, 2009; 24(3): 151 - 167.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
C. L. Ventura, R. Higdon, L. Hohmann, D. Martin, E. Kolker, H. D. Liggitt, S. J. Skerrett, and C. E. Rubens
Staphylococcus aureus Elicits Marked Alterations in the Airway Proteome during Early Pneumonia
Infect. Immun., December 1, 2008; 76(12): 5862 - 5872.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. D. van Zoelen, S. Florquin, J. C. M. Meijers, R. de Beer, A. F. de Vos, O. J. de Boer, and T. van der Poll
Platelet-Activating Factor Receptor Contributes to Host Defense against Pseudomonas aeruginosa Pneumonia but Is Not Essential for the Accompanying Inflammatory and Procoagulant Response
J. Immunol., March 1, 2008; 180(5): 3357 - 3365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Yende, D. C. Angus, J. Ding, A. B. Newman, J. A. Kellum, R. Li, R. E. Ferrell, J. Zmuda, S. B. Kritchevsky, T. B. Harris, et al.
4G/5G Plasminogen Activator Inhibitor-1 Polymorphisms and Haplotypes Are Associated with Pneumonia
Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1129 - 1137.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Renckens, J. J. T. H. Roelofs, P. I. Bonta, S. Florquin, C. J. M. de Vries, M. Levi, P. Carmeliet, C. van't Veer, and T. van der Poll
Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia
Blood, February 15, 2007; 109(4): 1593 - 1601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Q. Wang, K. Bdeir, S. Yarovoi, D. B. Cines, W. Fang, and E. Abraham
Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury
J. Immunol., October 15, 2006; 177(8): 5550 - 5557.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. E. Stegenga, S. N. van der Crabben, M. Levi, A. F. de Vos, M. W. Tanck, H. P. Sauerwein, and T. van der Poll
Hyperglycemia Stimulates Coagulation, Whereas Hyperinsulinemia Impairs Fibrinolysis in Healthy Humans
Diabetes, June 1, 2006; 55(6): 1807 - 1812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. van der Poll, M. Levi, J. A. Nick, and E. Abraham
Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in Humans
Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1125 - 1128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.